首页> 外文期刊>Medical science monitor: international medical journal of experimental and clinical research >Mortality at long-term follow-up of patients with no, nonobstructive, and revascularized 1-, 2-, and 3-vessel obstructive coronary artery disease.
【24h】

Mortality at long-term follow-up of patients with no, nonobstructive, and revascularized 1-, 2-, and 3-vessel obstructive coronary artery disease.

机译:无、无阻塞和血运重建的 1、2 和 3 支阻塞性冠状动脉疾病患者的长期随访死亡率。

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

BACKGROUND: To investigate the 5-year survival of patients with coronary angiographic evidence of no coronary artery disease (CAD), nonobstructive CAD, and revascularized 1-vessel, 2-vessel, and 3-vessel obstructive CAD. MATERIAL/METHODS: Coronary angiography was performed in 2,057 unselected patients, mean age 69 years (57 men and 43 women), with an acute coronary syndrome (50) or anginal chest pain.(50). RESULTS: Of 2,057 patients, 760 (37) had obstructive CAD with >50 obstruction of at least 1 major coronary artery (left anterior descending, left circumflex, and right coronary) and were revascularized, 695 (34) had nonobstructive CAD (<50 obstruction), and 602 (29) had normal coronary arteries. At 60+/-16-month follow-up, all-cause mortality occurred in 41 of 602 patients (7) with no CAD (group 1), in 80 of 695 patients (12) with nonobstructive CAD (group 2), in 50 of 302 patients (17) with revascularized 1-vessel obstructive CAD (group 3), in 47 of 201 patients (23) with 2-vessel revascularized obstructive CAD (group 4), and in 72 of 257 patients (28) with 3-vessel revascularized obstructive CAD (group 4). Log-rank tests to compare survival curves among the 5 groups showed p=0.004 for groups 1 versus 2; p<0.0001 for groups 1 versus 3, 1 versus 4, 1 versus 5, 2 versus 4, and 2 versus 5; and p=0.007 for groups 3 versus 5. CONCLUSIONS: Patients with nonobstructive CAD had a worse survival than those with no CAD, a nonsignificant difference in survival than those with revascularized 1-vessel obstructive CAD, and a better survival than those with revascularized 2-vessel or 3-vessel obstructive CAD.
机译:背景: 调查冠状动脉造影证据为无冠状动脉疾病 (CAD)、非阻塞性 CAD 和血运重建的 1 支、2 支和 3 支梗阻性 CAD 患者的 5 年生存率。 材料/方法: 对 2,057 例未经选择的患者进行了冠状动脉造影,平均年龄为 69 岁(57% 男性和 43% 女性),患有急性冠脉综合征 (50%) 或心绞痛。(50%).结果:在 2,057 例患者中,760 例 (37%) 患有阻塞性 CAD,>50% 的至少 1 条主要冠状动脉(左前降支、左回旋和右冠状动脉)梗阻并进行了血运重建,695 例 (34%) 患有非阻塞性 CAD(<50% 梗阻),602 例 (29%) 冠状动脉正常。在 60+/-16 个月的随访中,602 例无 CAD 患者中有 41 例 (7%)(第 1 组),695 例无阻塞性 CAD 患者中有 80 例 (12%) 发生全因死亡(第 2 组),302 例血运重建 1 支梗阻性 CAD 患者中有 50 例 (17%) 发生全因死亡(第 3 组),201 例患者中有 47 例 (23%) 患有 2 支血管血运重建梗阻性 CAD(第 4 组), 257 例患者中有 72 例 (28%) 患有 3 支血运重建性梗阻性 CAD(第 4 组)。比较 5 组生存曲线的对数秩检验显示,第 1 组与第 2 组的 p=0.004;第 1 组对 3 组、第 1 组对 4 组、第 1 组对第 5 组、第 2 组对第 4 组和第 2 组对第 5 组的 p<0.0001;第 3 组 vs 第 5 组的 p=0.007。结论:非梗阻性冠状动脉疾病患者的生存率低于无冠状动脉疾病患者,与血运重建的1支梗阻性冠状动脉疾病患者相比,生存率差异无统计学意义,比血运重建的2支或3支梗阻性冠状动脉疾病患者的生存率更高。

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号